Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
Clinical trial NCT06206265 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06206265
- Sponsor
- TRYP Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-17
- Primary completion
- 2026-03-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.